Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Controlled Clinical Trials
|
December 1, 1988
Some thoughts on one-tailed tests
K E Peace
Journal of Clinical Epidemiology
|
January 1, 1989
The alternative hypothesis: one-sided or two-sided?
K E Peace
Journal of Biopharmaceutical Statistics
|
January 1, 1991
One-sided or two-sided p values: which most appropriately address the question of drug efficacy?
K E Peace
Drug Information Journal
|
December 11, 1986
Design, monitoring, and analysis issues relative to adverse events
K E Peace
Biometrics
|
September 1, 1988
Some thoughts on one-tailed tests
K E Peace
Journal of Chronic Diseases
|
January 1, 1987
"Evaluable" vs "evaluatable": a postscript
K E Peace
Journal of Biopharmaceutical Statistics
|
March 1, 1993
Statistical methods for a three-period crossover design in which high dose cannot be used first
K E Peace, G G Koch
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1992
Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine
N H Holford, K E Peace
Journal of Chronic Diseases
|
January 1, 1987
p-value and power computations in multiple look trials
K E Peace, R C Schriver
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1992
Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine
N H Holford, K E Peace
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Controlled Clinical Trials
|
December 1, 1988
Some thoughts on one-tailed tests
K E Peace
Journal of Clinical Epidemiology
|
January 1, 1989
The alternative hypothesis: one-sided or two-sided?
K E Peace
Journal of Biopharmaceutical Statistics
|
January 1, 1991
One-sided or two-sided p values: which most appropriately address the question of drug efficacy?
K E Peace
Drug Information Journal
|
December 11, 1986
Design, monitoring, and analysis issues relative to adverse events
K E Peace
Biometrics
|
September 1, 1988
Some thoughts on one-tailed tests
K E Peace
Journal of Chronic Diseases
|
January 1, 1987
"Evaluable" vs "evaluatable": a postscript
K E Peace
Journal of Biopharmaceutical Statistics
|
March 1, 1993
Statistical methods for a three-period crossover design in which high dose cannot be used first
K E Peace, G G Koch
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1992
Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine
N H Holford, K E Peace
Journal of Chronic Diseases
|
January 1, 1987
p-value and power computations in multiple look trials
K E Peace, R C Schriver
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1992
Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine
N H Holford, K E Peace
Page
of 2